Sponsor Pipeline

Lingli Dong Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
1
Phase 3
2
Disease Areas
Active Trials by Phase
Phase 2/3
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07339566 Efficacy and Safety of Xeligekimab in the Treatment of Non-Radiographic Axial… Nr-axial Spondyloarthritis Not Yet Recruiting
Not specified
NCT06277427 Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting… Lupus Nephritis Recruiting
Disease Areas
Lupus (SLE) (1) Ankylosing Spondylitis (1)
Get alerts when Lingli Dong's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free